1. Home
  2. SEDG vs ALLO Comparison

SEDG vs ALLO Comparison

Compare SEDG & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEDG
  • ALLO
  • Stock Information
  • Founded
  • SEDG 2006
  • ALLO 2017
  • Country
  • SEDG Israel
  • ALLO United States
  • Employees
  • SEDG N/A
  • ALLO N/A
  • Industry
  • SEDG Semiconductors
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SEDG Technology
  • ALLO Health Care
  • Exchange
  • SEDG Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • SEDG 682.3M
  • ALLO 677.5M
  • IPO Year
  • SEDG 2015
  • ALLO 2018
  • Fundamental
  • Price
  • SEDG $10.74
  • ALLO $2.11
  • Analyst Decision
  • SEDG Hold
  • ALLO Buy
  • Analyst Count
  • SEDG 26
  • ALLO 12
  • Target Price
  • SEDG $28.11
  • ALLO $10.06
  • AVG Volume (30 Days)
  • SEDG 6.4M
  • ALLO 2.6M
  • Earning Date
  • SEDG 11-06-2024
  • ALLO 11-07-2024
  • Dividend Yield
  • SEDG N/A
  • ALLO N/A
  • EPS Growth
  • SEDG N/A
  • ALLO N/A
  • EPS
  • SEDG N/A
  • ALLO N/A
  • Revenue
  • SEDG $1,046,751,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • SEDG N/A
  • ALLO N/A
  • Revenue Next Year
  • SEDG $44.23
  • ALLO $5,902.96
  • P/E Ratio
  • SEDG N/A
  • ALLO N/A
  • Revenue Growth
  • SEDG N/A
  • ALLO 26.47
  • 52 Week Low
  • SEDG $10.24
  • ALLO $1.99
  • 52 Week High
  • SEDG $103.15
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • SEDG 31.12
  • ALLO 31.77
  • Support Level
  • SEDG $10.24
  • ALLO $1.99
  • Resistance Level
  • SEDG $11.45
  • ALLO $3.36
  • Average True Range (ATR)
  • SEDG 1.43
  • ALLO 0.21
  • MACD
  • SEDG -0.28
  • ALLO -0.11
  • Stochastic Oscillator
  • SEDG 4.61
  • ALLO 4.38

About SEDG SolarEdge Technologies Inc.

SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: